IL4 and lymphoma: As such, PARP14 has been implicated in mediating IL-4 induced attenuation of caspase-3 activation [45], i.e., increased PARP14 levels could contribute to protection against apoptosis and provide a survival advantage to STAT6MUT lymphoma cells.